Classification of myeloproliferative neoplasms and chronic myeloproliferative disorders

被引:0
|
作者
Kreipe, Hans H. [1 ]
机构
[1] Hannover Med Sch, Inst Pathol, Carl Neuberg Str 1, D-30625 Hannover, Germany
来源
ONKOLOGE | 2019年 / 25卷 / 11期
关键词
Polycythemia vera; Primary Myelofibrosis; Essential thrombocytosis; Driver mutations; Progress; CHRONIC IDIOPATHIC MYELOFIBROSIS; ESSENTIAL THROMBOCYTHEMIA; U2AF1; MUTATIONS; LEUKEMIA; CALRETICULIN; IMATINIB; JAK2;
D O I
10.1007/s00761-019-0577-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Myeloproliferative neoplasms (MPN, chronic myeloproliferative disorders according to the former nomenclature) comprise chronic myeloid leukemia (CML), BCR-ABL positive CML, polycythemia vera (PV), primary myelofibrosis (PMF), essential thrombocythemia (ET), chronic eosinophilic leukemia (CEL) and chronic neutrophilic leukemia (CNL). The MPNs have a biphasic course in common with initial overproduction of one or more blood cell lineages, followed by hematopoietic insufficiency because of a blast crisis and/or bone marrow fibrosis. Classification and prognosis require a combined approach of morphological investigations, frequently including bone marrow histology and molecular pathological analysis with detection of characteristic driver mutations as well as the course of additional modulating genetic aberrations.
引用
收藏
页码:957 / 970
页数:14
相关论文
共 50 条
  • [1] WHO classification 2022 of chronic myeloproliferative neoplasms
    Hochhaus, Andreas
    Ott, German
    Siebert, Reiner
    [J]. ONKOLOGIE, 2023, 29 (04): : 287 - 295
  • [2] Chronic myeloproliferative Neoplasms
    Griesshammer, M.
    Doehner, K.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (06) : 243 - 246
  • [3] Familial Chronic Myeloproliferative Neoplasms
    Alati, Caterina
    Martino, Bruno
    Marino, Antonio
    Ronco, Francesca
    Priolo, Manuela
    Nobile, Francesco
    [J]. BLOOD, 2010, 116 (21) : 1269 - 1269
  • [4] Chronic myeloproliferative neoplasms in the elderly
    Maffioli, Margherita
    Orlandi, Ester
    Passamonti, Francesco
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2018, 58 : 33 - 42
  • [5] Lymphoproliferative disorders in patients with chronic myeloproliferative neoplasms: A systematic review
    Marchetti, Monia
    Carobbio, Alessandra
    Capitoni, Enrica
    Barbui, Tiziano
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (05) : 698 - 703
  • [6] Chronic myeloproliferative disorders
    de Ozalla, CBA
    Suárez, JG
    [J]. REVISTA CLINICA ESPANOLA, 1999, 199 : 28 - 36
  • [7] Classification and Personalized Prognosis in Myeloproliferative Neoplasms
    Gappa, Birgit
    Griesshammer, Martin
    Sadjadian, Parvis
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (05) : 298 - +
  • [8] Introduction: Towards a molecular classification of chronic myeloproliferative disorders
    Petrides, PE
    [J]. MOLECULAR BASIS OF CHRONIC MYELOPROLIFERATIVE DISORDERS, 2004, : 3 - 9
  • [9] Chronic myeloproliferative disorders. The new WHO classification
    Thiele, J
    Kvasnicka, HM
    [J]. PATHOLOGE, 2001, 22 (06): : 429 - 443
  • [10] Classification and Personalized Prognosis in Myeloproliferative Neoplasms
    Grinfeld, J.
    Nangalia, J.
    Baxter, E. J.
    Wedge, D. C.
    Angelopoulos, N.
    Cantrill, R.
    Godfrey, A. L.
    Papaemmanuil, E.
    Gundem, G.
    MacLean, C.
    Cook, J.
    O'Neil, L.
    O'Meara, S.
    Teague, J. W.
    Butler, A. P.
    Massie, C. E.
    Williams, N.
    Nice, F. L.
    Andersen, C. L.
    Hasselbalch, H. C.
    Guglielmelli, P.
    McMullin, M. F.
    Vannucchi, A. M.
    Harrison, C. N.
    Gerstung, M.
    Green, A. R.
    Campbell, P. J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (15): : 1416 - 1430